Article
A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits…
medRxiv · 2022 · Shi, W.; Lv, L.; Liu, N.; Wang, H.; Wang, Y.; Zhu, W.; Liu, Z.; Zhu, J.; Lu, H.
Key facts
| Title | A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity |
|---|---|
| First author | Shi, W.; Lv, L.; Liu, N.; Wang, H.; Wang, Y.; Zhu, W.; Liu, Z.; Zhu, J.; Lu, H. |
| Journal | medRxiv |
| Published | Apr 1, 2022 |
| DOI | 10.1101/2022.03.15.484441 |
| Devices mentioned | K073490, K912666 |
| Product codes mentioned | CFN, LIQ, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1